XML 35 R5.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Statements of Changes in Stockholders’ Equity - 10-K - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Private GRI
Private GRI
Redeemable Common Stock
Private GRI
Convertible promissory notes
Private GRI
Bridge promissory note
Private GRI
Common Stock
Private GRI
Additional Paid-in Capital
Private GRI
Additional Paid-in Capital
Convertible promissory notes
Private GRI
Additional Paid-in Capital
Bridge promissory note
Private GRI
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2020           209,000              
Beginning balance at Dec. 31, 2020           $ 124              
Ending balance (in shares) at Dec. 31, 2021 7,816         209,000              
Ending balance at Dec. 31, 2021 $ 124       $ 124 $ 124              
Beginning balance (in shares) at Dec. 31, 2020                 22,688,511        
Beginning balance at Dec. 31, 2020         (4,945)       $ 227 $ 8,548     $ (13,720)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Issuance of common stock (in shares)                 76,923        
Issuance of common stock         100       $ 1 99      
Issuance of warrants and non-contingent beneficial ownership feature in connection with convertible promissory note         150         150      
Extinguishment of accrued compensation         1,406         1,406      
Net loss         $ (1,559)               (1,559)
Ending balance (in shares) at Dec. 31, 2021   851,419     22,765,434       22,765,434        
Ending balance at Dec. 31, 2021 $ (4,848) $ 0 $ 10,430 $ (15,278) $ (4,848)       $ 228 10,203     (15,279)
Ending balance (in shares) at Mar. 31, 2022 7,816                        
Ending balance at Mar. 31, 2022 $ 124                        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Net loss (302)     (302)                  
Ending balance (in shares) at Mar. 31, 2022   851,419                      
Ending balance at Mar. 31, 2022 $ (5,150) $ 0 10,430 (15,580)                  
Beginning balance (in shares) at Dec. 31, 2021 7,816         209,000              
Beginning balance at Dec. 31, 2021 $ 124       $ 124 $ 124              
Ending balance (in shares) at Sep. 30, 2022 7,816                        
Ending balance at Sep. 30, 2022 $ 124                        
Beginning balance (in shares) at Dec. 31, 2021   851,419     22,765,434       22,765,434        
Beginning balance at Dec. 31, 2021 (4,848) $ 0 10,430 (15,278) $ (4,848)       $ 228 10,203     (15,279)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Net loss (948)                        
Ending balance (in shares) at Sep. 30, 2022   851,419                      
Ending balance at Sep. 30, 2022 $ (5,706) $ 0 10,520 (16,226)                  
Beginning balance (in shares) at Dec. 31, 2021 7,816         209,000              
Beginning balance at Dec. 31, 2021 $ 124       124 $ 124              
Ending balance (in shares) at Dec. 31, 2022           0              
Ending balance at Dec. 31, 2022         $ 0 $ 0              
Beginning balance (in shares) at Dec. 31, 2021   851,419     22,765,434       22,765,434        
Beginning balance at Dec. 31, 2021 $ (4,848) $ 0 10,430 (15,278) $ (4,848)       $ 228 10,203     (15,279)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Issuance of warrants and non-contingent beneficial ownership feature in connection with convertible promissory note         60         60      
Warrant issuance             $ 30 $ 571     $ 30 $ 571  
Conversion of convertible promissory note (in shares)                 4,150,000        
Conversion of convertible promissory note         5,337       $ 41 5,296      
Restricted stock awards issued in satisfaction of accrued compensation         417         417      
Redemption of redeemable common stock (in shares)           (209,000)     (209,000)        
Redemption of redeemable common stock         0 $ (124)     $ (2) 2      
Vesting of restricted stock (in shares)                 25,000        
Stock-based compensation         25         25      
Net loss         $ (3,217)               (3,217)
Ending balance (in shares) at Dec. 31, 2022 999,748 999,748     26,731,434       26,731,434        
Ending balance at Dec. 31, 2022 $ (1,625) $ 0 16,871 (18,496) $ (1,625)       $ 267 16,604     (18,496)
Beginning balance (in shares) at Mar. 31, 2022 7,816                        
Beginning balance at Mar. 31, 2022 $ 124                        
Ending balance (in shares) at Jun. 30, 2022 7,816                        
Ending balance at Jun. 30, 2022 $ 124                        
Beginning balance (in shares) at Mar. 31, 2022   851,419                      
Beginning balance at Mar. 31, 2022 (5,150) $ 0 10,430 (15,580)                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Net loss (295)     (295)                  
Ending balance (in shares) at Jun. 30, 2022   851,419                      
Ending balance at Jun. 30, 2022 $ (5,445) $ 0 10,430 (15,875)                  
Ending balance (in shares) at Sep. 30, 2022 7,816                        
Ending balance at Sep. 30, 2022 $ 124                        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Issuance of warrants and non-contingent beneficial ownership feature in connection with convertible promissory note 60   60                    
Warrant issuance 30   30                    
Net loss (351)     (351)                  
Ending balance (in shares) at Sep. 30, 2022   851,419                      
Ending balance at Sep. 30, 2022 $ (5,706) $ 0 10,520 (16,226)                  
Beginning balance (in shares) at Dec. 31, 2022           0              
Beginning balance at Dec. 31, 2022         $ 0 $ 0              
Beginning balance (in shares) at Dec. 31, 2022 999,748 999,748     26,731,434       26,731,434        
Beginning balance at Dec. 31, 2022 $ (1,625) $ 0 16,871 (18,496) $ (1,625)       $ 267 16,604     (18,496)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Warrant issuance 532   532                    
Vesting of restricted stock (in shares)   467                      
Stock-based compensation 13   13                    
Net loss (2,150)     (2,150)                  
Ending balance (in shares) at Mar. 31, 2023   1,000,215                      
Ending balance at Mar. 31, 2023 $ (3,230) $ 0 17,416 (20,646)                  
Beginning balance (in shares) at Dec. 31, 2022           0              
Beginning balance at Dec. 31, 2022         $ 0 $ 0              
Beginning balance (in shares) at Dec. 31, 2022 999,748 999,748     26,731,434       26,731,434        
Beginning balance at Dec. 31, 2022 $ (1,625) $ 0 16,871 (18,496) $ (1,625)       $ 267 $ 16,604     $ (18,496)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Net loss $ (11,033)                        
Ending balance (in shares) at Sep. 30, 2023 2,956,354 2,956,354                      
Ending balance at Sep. 30, 2023 $ 2,227 $ 0 31,756 (29,529)                  
Beginning balance (in shares) at Mar. 31, 2023   1,000,215                      
Beginning balance at Mar. 31, 2023 (3,230) $ 0 17,416 (20,646)                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Vesting of restricted stock (in shares)   164,038                      
Stock-based compensation 13   13                    
Net loss (6,746)     (6,746)                  
Ending balance (in shares) at Jun. 30, 2023   2,956,354                      
Ending balance at Jun. 30, 2023 4,038 $ 0 31,430 (27,392)                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Stock-based compensation 326   326                    
Net loss $ (2,137)     (2,137)                  
Ending balance (in shares) at Sep. 30, 2023 2,956,354 2,956,354                      
Ending balance at Sep. 30, 2023 $ 2,227 $ 0 $ 31,756 $ (29,529)